PRHSX vs. FSMEX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Performance
PRHSX vs. FSMEX - Performance Comparison
Loading graphics...
PRHSX vs. FSMEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -9.65% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | -17.58% | 8.13% | 18.37% | 0.62% | -24.84% | 24.56% | 30.18% | 29.58% | 15.98% | 26.66% |
Returns By Period
In the year-to-date period, PRHSX achieves a -9.65% return, which is significantly higher than FSMEX's -17.58% return. Over the past 10 years, PRHSX has outperformed FSMEX with an annualized return of 11.42%, while FSMEX has yielded a comparatively lower 10.46% annualized return.
PRHSX
- 1D
- 0.37%
- 1M
- -9.33%
- YTD
- -9.65%
- 6M
- 18.49%
- 1Y
- 20.86%
- 3Y*
- 9.06%
- 5Y*
- 4.83%
- 10Y*
- 11.42%
FSMEX
- 1D
- -0.58%
- 1M
- -11.19%
- YTD
- -17.58%
- 6M
- -11.01%
- 1Y
- -8.83%
- 3Y*
- 0.36%
- 5Y*
- -0.71%
- 10Y*
- 10.46%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. FSMEX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is higher than FSMEX's 0.68% expense ratio.
Return for Risk
PRHSX vs. FSMEX — Risk / Return Rank
PRHSX
FSMEX
PRHSX vs. FSMEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | FSMEX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | -0.41 | +1.32 |
Sortino ratioReturn per unit of downside risk | 1.60 | -0.46 | +2.06 |
Omega ratioGain probability vs. loss probability | 1.20 | 0.94 | +0.26 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | -0.48 | +2.00 |
Martin ratioReturn relative to average drawdown | 4.47 | -1.55 | +6.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | FSMEX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | -0.41 | +1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | -0.03 | +0.30 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | 0.51 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.65 | -0.02 |
Correlation
The correlation between PRHSX and FSMEX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PRHSX vs. FSMEX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 26.63%, more than FSMEX's 12.78% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 26.63% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 12.78% | 10.53% | 17.04% | 0.00% | 1.80% | 8.12% | 6.65% | 1.77% | 7.47% | 6.26% | 5.84% | 16.35% |
Drawdowns
PRHSX vs. FSMEX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, which is greater than FSMEX's maximum drawdown of -40.34%. Use the drawdown chart below to compare losses from any high point for PRHSX and FSMEX.
Loading graphics...
Drawdown Indicators
| PRHSX | FSMEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -40.34% | -2.62% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -21.04% | +8.23% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -40.34% | +12.73% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -40.34% | +11.37% |
Current DrawdownCurrent decline from peak | -12.49% | -22.82% | +10.33% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -7.66% | -1.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.36% | 6.50% | -2.14% |
Volatility
PRHSX vs. FSMEX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 5.30%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 5.85%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | FSMEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.30% | 5.85% | -0.55% |
Volatility (6M)Calculated over the trailing 6-month period | 15.97% | 12.32% | +3.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.33% | 21.03% | +1.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.01% | 20.75% | -2.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.65% | 20.59% | -0.94% |